CVS Health (CVS) has reached a deal with the U.S. Federal Trade Commission to settle allegations that its drug benefit manager (PBM), Caremark, artificially inflated the price of insulin through an ...

The agreement would cover the company’s Caremark pharmacy benefit manager unit, which has denied wrongdoing.

CVS Health's Caremark has become the second of the "Big Three" pharmacy benefit managers to reach a settlement with the Federal Trade Commission (FTC) in a lawsuit over insulin pricing. | CVS Health's ...

Details have not yet been released, but CVS Health announced it has reached a settlement with the Federal Trade Commission ...

CVS Health said on Tuesday it has reached a proposed settlement agreement with the Federal Trade Commission ​on insulin ...

CVS Health Corp, a vertically integrated healthcare conglomerate, is headquartered in Woonsocket, Rhode Island. The company's ...

According to federal records, CVS Health has spent around $1.3 million on television ads across Tennessee in an effort to ...

CVS owns health insurer Aetna and pharmacy benefit manager Caremark, allowing it to control how medications are priced, ...

The Tennessee Attorney General warned CVS to stop texts on a bill banning PBMs from owning pharmacies, saying the messages ...

Charlotte organizations will use the CVS fund to expand food distribution and to improve health in Charlotte’s West End ...